Iliac Stent Market Size was valued at USD 1.02 Bn in 2023 and is predicted to reach USD 1.61 Bn by 2031 at a 6.07% CAGR during the forecast period for 2024-2031.
The iliac artery is one of the main pelvic arteries that supplies blood to the lower limbs. An iliac stent, a small tube device made of steel mesh, is designed to be implanted into this artery. Factors responsible for propelling the market for iliac stent diseases including technological developments in stents, an increase in angioplasty operations, a rise in the need for less intrusive operations, and the aging of the population. In addition, there are anticipated growth prospects for market players in the coming years due to the development of iliac stent materials and expansion into emerging markets. In addition, the market’s growth is anticipated to be hindered during the forecast period by the presence of alternative treatment techniques for cardiac illnesses, strict rules for product approval, and many product failures and recalls. Rising demand is further supported by the expanding recognition of iliac stenting’s advantages over other therapies, both among patients and healthcare providers. This will also drive the market growth in the coming years.
However, the market growth is hindered by obstacles such as problems occurring during the stenting process, the possibility of product failure, and the strict regulatory standards for the clearance of medical equipment. Global markets expanded during the coming years due to technological developments, and iliac stents are in high demand, increasing the prevalence of peripheral arterial disorders.
The iliac stent market is segmented based on type, artery lesions, and end-use. Based on type, the market is segmented into self-expandable stents, balloon-expandable stents, and others. By artery lesions, the market is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. By end-use, the market is segmented into hospitals, outpatient facilities, and others.
The self-expandable stents iliac stent market is expected to hold a significant global market share in 2022 because a self-expandable stent can widen and retain open the constricted or obstructed iliac arteries, allowing blood to flow freely to the lower extremities again. Leg pain, cramps, and numbness, signs of iliac artery occlusive disease, will go away with this. Additionally, the long-term patency of the treated artery can be better maintained using self-expandable iliac stents because they are made from robust materials. Positive results from long-term clinical studies are also likely to boost healthcare practitioners’ confidence.
The common iliac artery lesions segment is projected to grow rapidly in the global iliac stent market because a common iliac artery lesion is an abnormality or condition affecting the arteries that branch off the aorta and provide blood to the lower extremities and pelvis. The iliac arteries can develop various diseases, including atherosclerosis, stenosis, aneurysms, dissection, etc. Because obesity and high cholesterol both lead to plaque development, which restricts or clogs the artery lumen, the rising number of patients with these disorders is likely to increase the demand for iliac stents in this segment.
The North American iliac stent market is anticipated to register the highest market share in revenue in the near future. This can be attributed to drivers driving market expansion, including rising disease awareness, increased research and development for novel medicines, and the prevalence of arterial diseases. In addition, Asia Pacific is projected to fastest growing region in the markets because several factors are propelling the iliac stents market in this area, including the rising prevalence of cardiovascular disease in developing nations like China and India and the aging population in industrialized nations. Furthermore, the rising need for less intrusive treatments, the improvement of healthcare facilities, the expansion of insurance policies, and the growing public knowledge of peripheral artery disease all contribute to this industry's growth.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 1.02 Bn |
| Revenue Forecast In 2031 | USD 1.61 Bn |
| Growth Rate CAGR | CAGR of 6.07% from 2024 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, By Artery Lesions, By End-user and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | BD, Abbott, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Medtronic, Cook, Terumo Corporation, iVascular, Getinge AB and Biotronik SE & Co KG |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Iliac Stent Market-By Type
Iliac Stent Market-By Artery Lesions
Iliac Stent Market-By End-Use
Iliac Stent Market-By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.